Management of CMML
00:25:51

Management of CMML

In this presentation from "Great Debates and Updates in Hematologic Malignancies 2016", Dr. Eric Padron discusses the management of chronic myelomonocytic leukemia (CMML). A continuing education program is offered as a supplement to this webcast at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7204 © 2016 Imedex, LLC.

204 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Trending

Frontline KEYTRUDA In Gastroesophageal Cancer: Patients In Immunotherapy Arm Had Significantly Lower Side Effects
00:01:47

Frontline KEYTRUDA In Gastroesophageal Cancer: Patients In Immunotherapy Arm Had Significantly Lower Side Effects
26 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Advances in the treatment of ALL: how far have we come?
00:05:01

Advances in the treatment of ALL: how far have we come?
0 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Quality of life can impact PFS in ovarian cancer
00:01:28

Quality of life can impact PFS in ovarian cancer
79 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Addressing patient safety at the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015 | Dr Catherine Oakley
00:02:44

Addressing patient safety at the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015 | Dr Catherine Oakley
285 Views
4 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
iFCG yields unprecedented MRD negativity in CLL
00:02:41

iFCG yields unprecedented MRD negativity in CLL
64 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EGFR in Squamous Cell Carcinoma of the Head & Neck #hncs16
00:02:13

EGFR in Squamous Cell Carcinoma of the Head & Neck #hncs16
363 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How To Differentiate Between TKIs Available For Renal Cell Cancer Patients
00:01:22

How To Differentiate Between TKIs Available For Renal Cell Cancer Patients
97 Views
8 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Managing the “neglected” mediastinum and other surgical issues
00:21:56

Managing the “neglected” mediastinum and other surgical issues
445 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Evolving CML Research: Assessing the Need for Ongoing Treatment in Clinical Trials
00:09:39

Evolving CML Research: Assessing the Need for Ongoing Treatment in Clinical Trials
785 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Why Target These HPV-Associated Cancers?
00:00:38

Why Target These HPV-Associated Cancers?
463 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EHA 2016: Current research into JAK inhibtors- specifially ruxolitinib, pacritinib, and momelotinib
00:01:57

EHA 2016: Current research into JAK inhibtors- specifially ruxolitinib, pacritinib, and momelotinib
385 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Challenges in CLL - Richter's transformation and acute leukemia
00:01:57

Challenges in CLL - Richter's transformation and acute leukemia
782 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
0:16:51

Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
3 Views
20 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Perspectives on the Future of CML
0:26:35

Perspectives on the Future of CML
2 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease

2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Re-evaluating TKI in CML Patients During Pregnancy
0:15:04

Re-evaluating TKI in CML Patients During Pregnancy
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting
2 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CML and Pregnancy
0:15:30

CML and Pregnancy
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Lymphoblastic Leukemia

2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease

2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019

INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
4 Views
22 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
0:04:52

Phase 1/2 AUGMENT-101 Trial @sloan_kettering
13 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Melanoma Rates Decline Found in Younger Population
0:03:21

Melanoma Rates Decline Found in Younger Population
2 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
12 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
EE:EE:EE

What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
38 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Myelogenous Leukemia

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting
2 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
5 Views
5 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment
15 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How to Manage MDS Patients who are Ineligible for Transplant
00:01:47

How to Manage MDS Patients who are Ineligible for Transplant
300 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Recent Wave of Approval in AML
00:01:54

The Recent Wave of Approval in AML
138 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updated Data on Gilteritinib in AML
00:01:12

Updated Data on Gilteritinib in AML
16 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bladder Cancer

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
0:02:13

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
17 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EV-103 Phase I Trial Presented at #ESMO19
0:01:45

EV-103 Phase I Trial Presented at #ESMO19
24 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer
33 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer
23 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Strategies for Treating 2nd Line RCC Patients
00:01:17

Strategies for Treating 2nd Line RCC Patients
54 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating Newly Diagnosed RCC Patients
00:02:08

Treating Newly Diagnosed RCC Patients
53 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bone Metastases

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
00:00:40

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
194 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Brain Cancer

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
5 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence: How Does This Help Us?
0:03:05

Predicting Tumor Recurrence: How Does This Help Us?
7 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence
0:03:36

Predicting Tumor Recurrence
20 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How does this affect clinicians today?
0:01:20

How does this affect clinicians today?
7 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
0:01:26

Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
15 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncoceutics Commemorates National Childhood Cancer Awareness Month

Oncoceutics Commemorates National Childhood Cancer Awareness Month
14 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Breast Cancer

CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
6 Views
5 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
0:03:14

Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
2 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
0:02:49

Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
4 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Who is Eligible for the AVIATOR Study? @SeattleCCA
0:02:08

Who is Eligible for the AVIATOR Study? @SeattleCCA
2 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The AVIATOR Study @SeattleCCA
0:04:33

The AVIATOR Study @SeattleCCA
3 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer
8 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Business Management

Two Sided Payment Agreements & The Risks Involved
00:01:47

Two Sided Payment Agreements & The Risks Involved
116 Views
11 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MOASC COAnalyzer Tool Ricky Newton
01:01:00

MOASC COAnalyzer Tool Ricky Newton
99 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Cervical Cancer

Novel revelations in CLL biology with venetoclax/ibrutinib
00:02:24

Novel revelations in CLL biology with venetoclax/ibrutinib
93 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Immunotherapy in gynecological cancers: current and future landscape
00:02:35

Immunotherapy in gynecological cancers: current and future landscape
474 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Lymphocytic Leukemia

New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refrac...

New Long-Term Data Continues to Demonstrate Progression-Free Survival and Overall Survival Benefits with VENCLEXTA®/ VENCLYXTO® (venetoclax) Combination in Patients with Relapsed/Refrac...
2 Views
22 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase 3 DUO Study @ospniguarda
0:11:36

Phase 3 DUO Study @ospniguarda
9 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
00:04:47

ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
201 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
00:07:04

ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
92 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, What is the significance of IGHV mutations and how are they assessed
00:02:48

CLL, What is the significance of IGHV mutations and how are they assessed
87 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Not Your Fathers CLL with Dr. John Pagel
01:02:14

Not Your Fathers CLL with Dr. John Pagel
114 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Myelogenous Leukemia

Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
0:16:51

Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
3 Views
20 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Perspectives on the Future of CML
0:26:35

Perspectives on the Future of CML
2 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Re-evaluating TKI in CML Patients During Pregnancy
0:15:04

Re-evaluating TKI in CML Patients During Pregnancy
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CML and Pregnancy
0:15:30

CML and Pregnancy
1 Views
21 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating CML & Myelofibrosis Patients
00:01:34

Treating CML & Myelofibrosis Patients
319 Views
11 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Resistance/intolerance to second generation TKIs in CML: what to do next?
00:02:14

Resistance/intolerance to second generation TKIs in CML: what to do next?
155 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Colorectal Cancer

Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
0:02:35

Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
3 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
0:07:15

Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
23 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
BEACON Trial: What's Next?
0:02:57

BEACON Trial: What's Next?
11 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase 3 BEACON CRC Trial
0:04:43

Phase 3 BEACON CRC Trial
70 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
30 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login